![Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery | BioSpace Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery | BioSpace](https://mma.prnewswire.com/media/1983246/photo.jpg)
Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery | BioSpace
![Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials | Signal Transduction and Targeted Therapy Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsigtrans.2017.54/MediaObjects/41392_2017_Article_BFsigtrans201754_Fig1_HTML.jpg)
Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials | Signal Transduction and Targeted Therapy
![Time Trial: String Orchestra Conductor Score & Parts: Andrew H. Dabczynski - Digital Sheet Music Download Time Trial: String Orchestra Conductor Score & Parts: Andrew H. Dabczynski - Digital Sheet Music Download](https://static.alfred.com/cache/b7/8c/b78ce068ccd2dfdef609bea0baae3b41.png)
Time Trial: String Orchestra Conductor Score & Parts: Andrew H. Dabczynski - Digital Sheet Music Download
![Lymphoma Hub on X: "🔥CONGRESS #ASH21| @mana1981, @CUCancerCenter presented an interim analysis of the phase III TRANSFORM trial (SOC vs liso-cel as 2L therapy in pts with R/R #LBCL)➡️Median EFS and PFS Lymphoma Hub on X: "🔥CONGRESS #ASH21| @mana1981, @CUCancerCenter presented an interim analysis of the phase III TRANSFORM trial (SOC vs liso-cel as 2L therapy in pts with R/R #LBCL)➡️Median EFS and PFS](https://pbs.twimg.com/media/FGVZ8zXXMAgYppl.jpg:large)
Lymphoma Hub on X: "🔥CONGRESS #ASH21| @mana1981, @CUCancerCenter presented an interim analysis of the phase III TRANSFORM trial (SOC vs liso-cel as 2L therapy in pts with R/R #LBCL)➡️Median EFS and PFS
![Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress | Business Wire Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress | Business Wire](https://mms.businesswire.com/media/20230609005019/en/1128237/23/WUGEN-Logo-White-Background-FIN_copy.jpg)